News

The first CRISPR Medicine Conference 2024

The First CRISPR Medicine Conference | 23-25 April 2024 | Copenhagen, Denmark

- Apr. 23, 2024
News

Stay updated here

Tags

HashtagEventsHashtagCRISPRMED24

CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Recurrent or Progressive High-grade Glioma, (NCT06737146)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine